CompletedPhase 3NCT02174848
Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration
Studying Pantothenate kinase-associated neurodegeneration
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- ApoPharma
- Principal Investigator
- Elliott Vichinsky, MDUCSF Benioff Children's Hospital Oakland
- Intervention
- Deferiprone oral solution(drug)
- Enrollment
- 68 enrolled
- Eligibility
- 5 years · All sexes
- Timeline
- 2014 – 2018
Study locations (4)
- UCSF Benioff Children's Hospital Oakland, Oakland, California, United States
- Klinikum der Universität München, Munich, Germany
- Foundation Neurological Institute C. Besta, Milan, Italy
- Newcastle University Institute of Human Genetics, Newcastle upon Tyne, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02174848 on ClinicalTrials.gov